Baby KJ, in a tiny tuxedo, shows up at the #STATSummit. His parents Kyle and Nicole Muldoon give an update on how he’s doing after his life-saving CRISPR treatment for a rare liver disease earlier this year.

Catch @DavidFajgenbaum on @FOX29philly this morning! He’s talking about his mission to repurpose already approved drugs… and the major motion picture about his life!

Congratulations to @ScottHalpernMD (@PAIRCenter), Jason Christie (@PennPulmonary) & @Michael_Harhay (@UPennDBEI) on being named @atscommunity 2025 Respiratory Health Awardees! https://t.co/yUKgmxINjW

CHOP & @PennMedicine have delivered the first-ever personalized gene editing therapy for a patient with CPS1 deficiency, marking a major milestone in the application of CRISPR-based treatments. Learn more about KJ & the future of personalized medicine: https://t.co/A9DTcNmxrR.

Breaking News: A baby with a rare disorder made medical history by receiving the first custom gene-editing treatment. The technique used has the potential to help people with thousands of other uncommon genetic diseases.

For the first time in 45 years, a new subtype of Castleman disease has been identified, allowing patients to receive the right treatment for their condition ft. @DavidFajgenbaum (@PennMedicine) & @JBrandMDPhD (@PennCancer) @CureCastleman https://t.co/wXrD1yk7pX

In April, @Penn_Transplant performed a record-breaking 67 transplants. No better way to mark #DonateLifeMonth than by saving more lives in one month than ever before. Consider becoming an organ donor and give the gift of life: https://t.co/LfNRrsJo6W

A 76-year-old grandfather brushed off an odd chest flutter—then learned his aorta was about to burst. With his grandson’s future on the line, Penn Medicine’s Aortic team saved his life.

Thank you to the @76ers for recognizing our #TAVR leadership team! The Penn TAVR Program is one of the largest & highest-rated programs of its kind, achieving the highest distinction of 3 ⭐s by @STS_CTsurgery / ACC TVT registry. @PennMedicine @NimeshDesaiMD @howard_herrmann

'I'm a heart transplant recipient. I'm disabled, and I beat cancer': Young woman shares health struggles, how she wants to help others @GraceGriffaton reports.

Congratulations to @jennlewey and @LisaObdoc on receiving @PCORI funding for a study addressing postpartum hypertension. This research compares "low-touch" and "high-touch" blood pressure management programs. @PennOBGYN

Last week, the AHA and Penn Medicine launched the “Team Up to Take Down High Blood Pressure” initiative with Family Practice and Counseling Network, Greater Philadelphia Health Action, Spectrum Health Services, Southwest CDC and Second Antioch Baptist Church.

Today the @AHAPennsylvania and @PennMedicine announced a three year movement called Team Up to Take Down High Blood Pressure. The goal? Lower the blood pressure of folks living in West & Southwest Philadelphia, where more than 1 in 3 people suffer from high blood pressure.

New work from Mitch Lazar's laboratory highlighting a connection between liver clock, feeding and activity rhythms via hepatic vagal afferent signaling @MitchLazar1 https://t.co/HeQrOwl6b7

New research led by @emilyvailmd of @PennAnesthesia finds better survival rates for recipients of lungs from hospital-based donor care units compared to independent donor care units.

Here's a bit of transplant medicine history—you can all stop hounding me for it!—and a new study that raises questions about what kind of organ donation setup is actually best for transplant recipients. 🔓 https://t.co/wuNKeI2FW6

Check out a preview of the @Penn_Transplant research that will be presented at the @ATCMeeting in Philadelphia from June 1-5, covering topics such as living donor liver transplantation, interventions to improve early #transplant outcomes, and more.

Dozens of @PennMedicine experts in the fields of heart and lung transplant are in Prague this week to attend @ISHLT 2024. A sneak peek of Penn presenters and remarks by @ISHLTPres can be found in this media tool kit! Best of luck to all attending.

Using a genetically engineered pig liver, @Penn_Transplant researchers successfully circulated a deceased donor's blood outside the body. A promising step towards a more effective "bridge" for critically ill patients awaiting liver transplants.

A @PennMedicine research team announced the first successful completion of an experiment to circulate a recently deceased donor’s blood through a genetically engineered pig liver outside their body.